Propel Bio Management »

Achieve Life Sciences shares owned by Propel Bio Management

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $12M 2.5M 4.70
2024-03-31 $11M 2.5M 4.55

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (PAGP)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Achieve Life Sciences Comm (ACHV)
Phathom Pharmaceuticals I Comm (PHAT)
Akero Therapeutics Comm (AKRO)
Avidity Biosciences Comm (RNA)
Ardelyx Comm (ARDX)
Abeona Therapeutics Comm (ABEO)
Fulcrum Therapeutics Comm (FULC)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Verrica Pharmaceuticals I Comm (VRCA)
Kura Oncology Comm (KURA)

View all positions for Propel Bio Management

Top funds holding Achieve Life Sciences

Franklin Resources
Propel Bio Management
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Geode Capital Management
Nantahala Capital Management
Alyeska Investment Group
Shay Capital
State Street Corporation
Northern Trust
Long Focus Capital Management
Simplify Asset Management
Altium Capital Management

View all funds holding Achieve Life Sciences